Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 03/31/2019

Month EndAs of 04/30/2019 1 Yr 3 Yr 5 Yr 10 Yr Since Inception Inception 09/15/1997
Fund without Sales Charge (%) (NAV) -1.36 6.56 6.41 16.10 10.73
Fund with Sales Charge (%) (POP) -1.36 6.56 6.41 16.10 10.73
NASDAQ Biotechnology Index (%) 2.71 6.02 6.85 17.50 11.44
S&P 500 Index (%) 13.49 14.88 11.63 15.32 7.54
Quarter EndAs of 03/31/2019 1 Yr 3 Yr 5 Yr 10 Yr Since Inception Inception 09/15/1997
Fund without Sales Charge (%) (NAV) 0.79 9.74 5.83 16.21 11.04
Fund with Sales Charge (%) (POP) 0.79 9.74 5.83 16.21 11.04
NASDAQ Biotechnology Index (%) 4.71 8.81 7.33 17.94 11.74
S&P 500 Index (%) 9.50 13.52 10.91 15.92 7.37

Calendar Year Returns

2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund without Sales Charge (%) (NAV) -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64 11.93
Fund with Sales Charge (%) (POP) -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64 11.93
NASDAQ Biotechnology Index (%) -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25 15.84
S&P 500 Index (%) -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06 26.46

Cumulative Total Returns [further-information] As of 03/31/2019

Month EndAs of 04/30/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 13.56 -1.36 20.98 36.46 344.96 806.58
Fund with Sales Charge (%) (POP) 13.56 -1.36 20.98 36.46 344.96 806.58
NASDAQ Biotechnology Index (%) 9.84 2.71 19.17 39.30 401.71 939.26
S&P 500 Index (%) 18.25 13.49 51.58 73.32 316.02 381.03
Quarter EndAs of 03/31/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 19.46 0.79 32.16 32.73 349.12 853.70
Fund with Sales Charge (%) (POP) 19.46 0.79 32.16 32.73 349.12 853.70
NASDAQ Biotechnology Index (%) 15.40 4.71 28.80 42.42 420.79 991.89
S&P 500 Index (%) 13.65 9.50 46.25 67.81 338.09 362.31

After-Tax Average Annual Total Returns [further-information] As of 03/31/2019

Month EndAs of 04/30/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -2.43 5.50 5.01 14.86
Fund without Sales Charge (%) (NAV) After Shares Sold -0.60 4.82 4.69 13.36
Fund with Sales Charge (%) (POP) Before Shares Sold -2.43 5.50 5.01 14.86
Fund with Sales Charge (%) (POP) After Shares Sold -0.60 4.82 4.69 13.36
Quarter EndAs of 03/31/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -0.31 8.66 4.43 14.97
Fund without Sales Charge (%) (NAV) After Shares Sold 0.63 7.28 4.18 13.42
Fund with Sales Charge (%) (POP) Before Shares Sold -0.31 8.66 4.43 14.97
Fund with Sales Charge (%) (POP) After Shares Sold 0.63 7.28 4.18 13.42

SALES CHARGE, EXPENSES & FEES As of 09/01/2018 (updated annually)

Gross Expense Ratio 0.79%
Net Expense Ratio [further-information] 0.77%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 04/30/2019 Updated Monthly, based on a 3-year period

Beta 1.01
Sharpe Ratio 0.24
Standard Deviation 22.31

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index

You need Adobe Acrobat Reader 6.0 or higher to view and print PDF documents. Download a free version from Adobe's website.